ArticleDiscover oncology2026
Training and validation of a 1D CNN model for accurate three-class classification of oral cancer using serum Raman spectroscopy.
Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, a one-dimensional convolutional neural network (1D-CNN) was developed for classifying serum Raman spectra into three oral cancer-related classes: normal, precancerous, and cancerous. To address class imbalance, class-weighted learning was employed during training, while augmentation was evaluated separately as a comparative strategy. The final selected non-augmented model achieved an overall testing accuracy of 83%, with a macro-precision of 85%, macro-recall of 84%, and macro-F1 score of 83%, indicating balanced three-class performance. To further assess real-world applicability, an independent test dataset collected later from the same hospital was used. This cohort followed the same acquisition and preprocessing protocol but consisted of entirely new patients. The model maintained consistent classification performance on this independent dataset, supporting its generalizability within the same clinical environment. These findings highlight the potential of combining Raman spectroscopy with deep learning as a non-invasive framework for oral cancer-related biosample classification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.